Merck and ISB Collaborate to Understand and Treat SARS-CoV-2 Infection
heath.isbscience.org/2020/04/27/merck-isb-covid/
heath.isbscience.org/2020/04/27/merck-isb-covid/Recent Articles
Looking at Tumors Through a New Lens
To improve the efficacy of neoadjuvant immune checkpoint blockade against glioblastoma, researchers are looking for vulnerabilities in surgically removed tissues – a difficulty due to the vast differences within the tumor and between patients. To address this, ISB researchers and their collaborators developed a new way to study tumors.
Three Collaborative Projects Announced for ISB’s 2021 Innovator Award Program
ISB has kicked off the fifth year of its Innovator Award Program by announcing three collaborative and cross-disciplinary projects. The program was created in 2017 to support early-career scientists working on high-risk, high-reward innovations, and champions interdisciplinary collaboration for non-faculty ISB researchers.
ISB Undergraduate Researcher Daniel Chen Earns Goldwater Scholarship
Daniel Chen, an undergraduate researcher in ISB’s Heath Lab and junior at the University of Washington, has been awarded a prestigious Goldwater Scholarship. Chen has been a key member of ISB’s COVID-19 Immune Response Study.